Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: Jim who wrote (619)	4/4/1999 9:46:00 PM
From: JF2155	Read Replies (2) \| Respond to of 2515

Jim --SUGN was that drug maker on 60min but it was noted that many other trials are trying to beat this cancer devil. IMCL results fair much better than SUGN ( but only for head and neck )so maybe the market will notice this. SUGN should have a great day monday on the shows upbeat nature in combating cancer. Great show by 60 min --one of its best . It should be noted that SUGN drug was trying to work on many types /locations of cancer tumors--very tough job indeed JIM